tirzepatide news 2025 Leads Pharma Growth in with $11.4B in Sales | Brian K. Buntz posted on the topic ESC 2025: study supports use

After that, they often discontinue the drug or switch to a lower, maintenance dose. Early studies suggest that some patients may hold their weight loss for a time after stopping the medication but many likely will experience weight gain

Month 2 - 20 mg Month 5 - 50 mg

It stimulates GH release without significantly elevating cortisol or prolactin (Raun et al., Eur J Endocrinol 1998)

Beschleunigte Zellerneuerung

While insurance companies may not cover every indication (i.e., medical reason to take a drug), doctors are increasingly prescribing GLP-1s to a wider array of people with health concerns tied to carrying around excess weight, including joint pain, inflammation, and high blood pressure